Fulgent Genetics (FLGT) Current Assets (2015 - 2026)

Fulgent Genetics has disclosed Current Assets across 12 years of filings, most recently posting $479.0 million for Q1 2026.

• Current Assets for Q1 2026 came in at $479.0 million, up 14.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $479.0 million (up 14.94% YoY), and the FY2025 annual result was $550.5 million, up 55.69% from the prior year.
• Current Assets came in at $479.0 million for Q1 2026 at Fulgent Genetics, down from $550.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $765.3 million in Q1 2022 to a low of $326.5 million in Q3 2024.
• The 5-year median for Current Assets is $507.8 million (2023), against an average of $516.5 million.
• Across the five-year window, Current Assets sank 40.61% in 2024 and soared 55.69% in 2025, its largest moves.
• Fulgent Genetics' Current Assets stood at $627.9 million in 2022, then retreated by 19.12% to $507.8 million in 2023, then tumbled by 30.38% to $353.6 million in 2024, then surged by 55.69% to $550.5 million in 2025, then fell by 12.98% to $479.0 million in 2026.
• The last three Current Assets figures came in at $479.0 million (Q1 2026), $550.5 million (Q4 2025), and $507.4 million (Q3 2025), per Business Quant data.